The report highlights that the "China+1" strategy, which involves companies diversifying operations beyond China, has opened doors for other Asian countries, including India. This shift is driving investments into India's pharma sector, enabling it to expand beyond its traditional focus on g
Mumbai (Maharashtra) [India], June 8 (ANI): India Ratings and Research (Ind-Ra) has assigned Adani Ports and Special Economic Zone (APSEZ) Ltd's non-convertible debentures (NCDs) a final rating of AA-plus with a stable outlook.